Enzymatically Active Paraoxonase-1 Is Located at the External Membrane of Producing Cells and Released by a High Affinity, Saturable, Desorption Mechanism

This publication has 38 references indexed in Scilit:

• The paraoxonase Leu–Met54 and Gln–Arg191 gene polymorphisms are not associated with the risk of coronary heart disease
  Atherosclerosis, 2000
• Human Serum Paraoxonase/Arylesterase’s Retained Hydrophobic N -Terminal Leader Sequence Associates With HDLs by Binding Phospholipids
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Charting the Fate of the “Good Cholesterol”: Identification and Characterization of the High-Density Lipoprotein Receptor SR-BI
  Annual Review of Biochemistry, 1999
• Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states
  Atherosclerosis, 1998
• Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
  Journal of Clinical Investigation, 1998
• Reconstituted High-Density Lipoproteins with a Disulfide-Linked Apolipoprotein A-I Dimer: Evidence for Restricted Particle Size Heterogeneity
  Biochemistry, 1997
• Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
  Journal of Clinical Investigation, 1997
• Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Novel apoprotein A-I-containing lipoprotein produced by a human hepatoma-derived cell line HuH-7
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
• THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM
  Journal of Clinical Investigation, 1955